1. 'Swollen heart' in the course of acute intermittent porphyria associated with severe hyponatraemia. (7th September 2022) Authors: Jaworski, Krzysztof; Wasilewski, Robert; Szwed, Hanna; Windyga, Jerzy; Dabrowski, Rafal Journal: European heart journal Issue: Volume 23:Number 12(2022) Page Start: e544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addressing unmet needs in rare bleeding disorders: selected poster extracts of recent research in hemophilia A and von Willebrand disease presented at the 14th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) (Feb 3–5, 2021; virtual congress). (23rd September 2021) Authors: Allen, Geoffrey; Du, Ping; Khair, Kate; Lee, Hye-Youn; Ozelo, Margareth C.; Berthoz, Françoise Truong; Windyga, Jerzy Journal: Expert review of hematology Issue: Volume 14:Supplement 1(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group. Issue 1 (21st October 2022) Authors: Klamroth, Robert; Ay, Cihan; De Moerloose, Philippe; Fontana, Pierre; Windyga, Jerzy; Astermark, Jan; Berntorp, Erik; Carvalho, Manuela; Dolan, Gerard; Hermans, Cedric; Holme, Pål Andre; Kenet, Gili; Mancuso, Maria Elisa; Marquardt, Natascha; Nunez, Ramiro; Pabinger, Ingrid; Rodgers, Ryan; Valk, ... Journal: Haemophilia Issue: Volume 29:Issue 1(2023) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B. Issue 3 (June 2014) Authors: Windyga, Jerzy; Abbuehl, Brigitt E; Hafeman, Andrea E Journal: Expert review of hematology Issue: Volume 7:Issue 3(2014) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BAX326 (RIXUBIS): a novel recombinant factor IX for the control and prevention of bleeding episodes in adults and children with hemophilia B. (October 2014) Authors: Windyga, Jerzy; Solano Trujillo, Maria Helena; Hafeman, Andrea E. Journal: Therapeutic advances in hematology Issue: Volume 5:Number 5(2014:Oct.) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review. (July 2018) Authors: Mahlangu, Johnny N.; Ahuja, Sanjay P.; Windyga, Jerzy; Church, Nikki; Shah, Anita; Schwartz, Lawrence Journal: Therapeutic advances in hematology Issue: Volume 9:Number 7(2018) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Changing paradigms of hemophilia care across larger specialized treatment centers in the European region. (March 2022) Authors: Windyga, Jerzy; Boban, Ana; Zupan, Irena; O'Connell, Niamh; Hermans, Cedric Journal: Therapeutic advances in hematology Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data. Issue 1 (8th November 2018) Authors: Eichler, Hermann; Angchaisuksiri, Pantep; Kavakli, Kaan; Knoebl, Paul; Windyga, Jerzy; Jiménez‐Yuste, Victor; Harder Delff, Philip; Chowdary, Pratima Journal: Haemophilia Issue: Volume 25:Issue 1(2019) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Disease Characteristics of Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial: 996. (October 2019) Authors: Anderson, Karl; Balwani, Manisha; Sardh, Eliane; Gouya, Laurent; Rees, David; Stein, Penelope; Stolzel, Ulrich; Aguilera, Paula; Bissell, Montgomery D.; Bonkovsky, Herbert; Keel, Sioban; Parker, Charles; Phillips, John; Silver, Samuel; Windyga, Jerzy; D'Avola, Delia; Ross, Gayle; Stewart, Peter; ... Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Issue 3 (March 2023) Authors: Négrier, Claude; Mahlangu, Johnny; Lehle, Michaela; Chowdary, Pratima; Catalani, Olivier; Bernardi, Ronald J; Jiménez-Yuste, Víctor; Beckermann, Benjamin M; Schmitt, Christophe; Ventriglia, Giuliana; Windyga, Jerzy; d'Oiron, Roseline; Moorehead, Paul; Koparkar, Sunita; Teodoro, Vanda; Shapiro, Am... Journal: Lancet Issue: Volume 10:Issue 3(2023) Page Start: e168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗